$1.03
-0.04-3.27%
At close: -
$1.05
0.021.50%
After Hours: 7:54 AM EDT
Comments
Loading...
Clearmind Medicine Earnings Estimates, EPS & Revenue | NASDAQ:CMND | Benzinga
Clearmind Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 13
EPS
$-0.240
Quarterly Revenue
$0.00
Annual Revenue
(as of Jan 31)
(as of Jan 31)
–
Analyze the earnings history of Clearmind Medicine using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CMND | Clearmind Medicine | -$0.28 | — | — | — | $0.00 | — | — | — | 06/12/2025 | Get Alert |
| CMND | Clearmind Medicine | -$0.90 | — | -$0.24 | — | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
| CMND | Clearmind Medicine | — | — | -$0.11 | — | — | — | $0.00 | — | 01/22/2025 | Get Alert |
| CMND | Clearmind Medicine | -$2.43 | — | -$0.59 | — | $0.00 | — | $0.00 | — | 09/16/2024 | Get Alert |
| CMND | Clearmind Medicine | -$16.62 | — | -$0.28 | — | $0.00 | — | $0.00 | — | 06/13/2024 | Get Alert |
Clearmind Medicine (CMND) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Clearmind Medicine (CMND) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Clearmind Medicine (NASDAQ:CMND) reporting earnings?
Clearmind Medicine (CMND) is scheduled to report earnings on June 12, 2025. The last reported earnings were for reported on March 13, 2025 for Q1.
What were the latest earnings per share (EPS) for Clearmind Medicine (NASDAQ:CMND)?
The Actual EPS was $-0.24, which missed the estimate of $0.00.
What were Clearmind Medicine’s (NASDAQ:CMND) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.